RE:Stonegate Research Report released. Nicely done. Conservative revenue number used for 2022 at 28.1 million. Considering they hope to ramp up their manufacturing to 40 million per year capacity, as well as having the only 100 MHz NMR product in the market to support the pipeline, seems to be very achievable. Low end current valuation of $1.27 offers good support and limited downside which should help boost the price a bit closer to the $2.10 mid point valuation.
It will be curious to see how the market responds tomorrow (if at all). I'm in this for the long, so loving this year so far. Well managed, nice little company that will turn some heads in the short term IMO.